Eli Gilboa

Eli Gilboa

Company: University of Miami, Miller School of Medicine

Job title: Director, Dodson Interdisciplinary Immunotherapy Institute


Vaccination Against Shared Neoantigens Induced in Recurrent and Future Tumors 4:15 pm

• A common set of neoantigens are induced in disseminated tumor lesions by tumor targeted siRNA mediated inhibition of the peptide transporter TAP. • Vaccination against TAP downregulation induced neoantigens by targeted inhibition of TAP in resident dendritic cells Inhibited tumor growth in transplantable and autochthonous murine tumor models that was superior to vaccination against…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.